NEW YORK , Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK , Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Reddit, Inc. ("Reddit" or the "Company") (NYSE: RDDT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK , Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") (NASDAQ: RCKT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK , Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Vestis Corporation ("Vestis" or the "Company") (NYSE: VSTS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK , Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against RxSight, Inc. ("RxSight" or the "Company")(NASDAQ: RXST). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

NEW YORK , Aug. 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation ("Neogen" or the "Company") (NASDAQ: NEOG). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

Disney's streaming businesses will merge next year.

Shares of Meta Platforms Inc. (NASDAQ: META) lost 1.57% over the past five trading sessions, but the Magnificent Seven mainstay has still enjoyed a 27.40% year-to-date gain.

SMG tops Q3 earnings estimates on stronger margins, but sales fall short amid a sharp Hawthorne segment decline.

OPENLANE (KAR) came out with quarterly earnings of $0.33 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.19 per share a year ago.

Bioventus (BVS) came out with quarterly earnings of $0.21 per share, missing the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.19 per share a year ago.

The New York Times Company (NYSE:NYT ) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Anthony Joseph DiClemente - Senior Vice President of Investor Relations Meredith A. Kopit Levien - CEO, President & Director William Bardeen - Executive VP & Chief Financial Officer Conference Call Participants Benjamin Soff - Deutsche Bank AG, Research Division David Karnovsky - JPMorgan Chase & Co, Research Division Douglas Middleton Arthur - Huber Research Partners, LLC Jason Boisvert Bazinet - Citigroup Inc. Exchange Research Kutgun Maral - Evercore ISI Institutional Equities, Research Division Thomas L.

On a quiet day for macroeconomic news, earnings dominate market action Wednesday morning.

MOS posts Q2 earnings miss as lower phosphate volumes weigh on results despite higher margins.

Kennametal (KMT) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Build-A-Bear (BBW) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Pitney Bowes (PBI) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.

Quad/Graphics (QUAD) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Aurora Cannabis Inc. (ACB) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of $0.18. This compares to a loss of $0.11 per share a year ago.